Resource Center
Our white paper on SARS-CoV-2 serology providing an in-depth analysis of the role of serological testing in understanding immune responses to COVID-19. It discusses the different types of serological assays available, their relevance for diagnosing past infections, and their utility in public health strategies. The paper also emphasizes the importance of accurately interpreting serology results in the context of vaccination and natural infection, offering insights for healthcare providers and researchers. Download this comprehensive resource for understanding the complexities of SARS-CoV-2 serology during the pandemic.
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.